or
forgot password

National Breast Cancer and Lymphedema Registry


N/A
18 Years
N/A
Open (Enrolling)
Both
Breast Cancer, Lymphedema

Thank you

Trial Information

National Breast Cancer and Lymphedema Registry


Historically, breast cancer-associated lymphedema has been relatively ignored, with
mis-diagnosis, late diagnosis, and failure to treat. The condition has a measurable,
substantial impact on patient function and perceived quality of life (QOL). Recent pilot
studies suggest that interventions that are designed to facilitate early diagnosis and
preventive strategies have a major impact on the incidence and severity of disease burden.
This registry is designed to prospectively capture the relevant data to document the impact
of preemptive diagnostic and treatment strategies.


Inclusion Criteria:



- Breast cancer survivorship

Exclusion Criteria:

- Age < 18 years old

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Preemptive diagnostic and treatment strategies

Outcome Description:

The methods for lymphedema surveillance and detection will be correlated to the new appearance of lymphedema in this cohort of breast cancer survivors. We will also assess severity of lymphedema and responsiveness to treatment strategies.

Outcome Time Frame:

Each enrolled patient will be followed for an average of 1 year

Safety Issue:

No

Principal Investigator

Stanley G Rockson

Investigator Role:

Principal Investigator

Investigator Affiliation:

Stanford University

Authority:

United States: Institutional Review Board

Study ID:

SU-10042011-8529

NCT ID:

NCT01580800

Start Date:

September 2011

Completion Date:

December 2025

Related Keywords:

  • Breast Cancer
  • Lymphedema
  • Breast Neoplasms
  • Lymphedema

Name

Location
Stanford University School of Medicine Stanford, California  94305-5317